566 related articles for article (PubMed ID: 23293059)
21. Human stem cell research and regenerative medicine--present and future.
Volarevic V; Ljujic B; Stojkovic P; Lukic A; Arsenijevic N; Stojkovic M
Br Med Bull; 2011; 99():155-68. PubMed ID: 21669982
[TBL] [Abstract][Full Text] [Related]
22. Pluripotent human stem cells: A novel tool in drug discovery.
Phillips BW; Crook JM
BioDrugs; 2010 Apr; 24(2):99-108. PubMed ID: 20199125
[TBL] [Abstract][Full Text] [Related]
23. Transcriptomic concentration-response evaluation of valproic acid, cyproconazole, and hexaconazole in the neural embryonic stem cell test (ESTn).
Theunissen PT; Robinson JF; Pennings JL; de Jong E; Claessen SM; Kleinjans JC; Piersma AH
Toxicol Sci; 2012 Feb; 125(2):430-8. PubMed ID: 22045034
[TBL] [Abstract][Full Text] [Related]
24. Use of human embryonic stem cell-based models for male reproductive toxicity screening.
Krtolica A; Giritharan G
Syst Biol Reprod Med; 2010 Jun; 56(3):213-21. PubMed ID: 20536321
[TBL] [Abstract][Full Text] [Related]
25. Exploiting pluripotent stem cell technology for drug discovery, screening, safety, and toxicology assessments.
McGivern JV; Ebert AD
Adv Drug Deliv Rev; 2014 Apr; 69-70():170-8. PubMed ID: 24309014
[TBL] [Abstract][Full Text] [Related]
26. Challenges of using pluripotent stem cells for safety assessments of substances.
Vojnits K; Bremer S
Toxicology; 2010 Mar; 270(1):10-7. PubMed ID: 20004228
[TBL] [Abstract][Full Text] [Related]
27. Progress made in the reprogramming field: new factors, new strategies and a new outlook.
Hussein SM; Nagy AA
Curr Opin Genet Dev; 2012 Oct; 22(5):435-43. PubMed ID: 22959308
[TBL] [Abstract][Full Text] [Related]
28. Human embryonic stem cells: A journey beyond cell replacement therapies.
Menendez P; Bueno C; Wang L
Cytotherapy; 2006; 8(6):530-41. PubMed ID: 17148029
[TBL] [Abstract][Full Text] [Related]
29. Stem cells in toxicology: fundamental biology and practical considerations.
Kang KS; Trosko JE
Toxicol Sci; 2011 Mar; 120 Suppl 1():S269-89. PubMed ID: 21163910
[TBL] [Abstract][Full Text] [Related]
30. Can human embryonic stem cells contribute to the discovery of safer and more effective drugs?
Cezar GG
Curr Opin Chem Biol; 2007 Aug; 11(4):405-9. PubMed ID: 17662644
[TBL] [Abstract][Full Text] [Related]
31. Systematic approaches to toxicology in the zebrafish.
Peterson RT; Macrae CA
Annu Rev Pharmacol Toxicol; 2012; 52():433-53. PubMed ID: 22017682
[TBL] [Abstract][Full Text] [Related]
32. Commentary on ''Toxicity testing in the 21st century: a vision and a strategy'': stem cells and cell-cell communication as fundamental targets in assessing the potential toxicity of chemicals.
Trosko JE
Hum Exp Toxicol; 2010 Jan; 29(1):21-9. PubMed ID: 20061464
[TBL] [Abstract][Full Text] [Related]
33. Human Embryonic and Induced Pluripotent Stem Cell Based Toxicity Testing Models: Future Applications in New Drug Discovery.
Shinde V; Sureshkumar P; Sotiriadou I; Hescheler J; Sachinidis A
Curr Med Chem; 2016; 23(30):3495-3509. PubMed ID: 27356535
[TBL] [Abstract][Full Text] [Related]
34. Embryonic stem cells in safety pharmacology and toxicology.
Stummann TC; Bremer S
Adv Exp Med Biol; 2012; 745():14-25. PubMed ID: 22437810
[TBL] [Abstract][Full Text] [Related]
35. Improved preclinical safety assessment using micro-BAL devices: the potential impact on human discovery and drug attrition.
Giri S; Bader A
Drug Discov Today; 2011 May; 16(9-10):382-97. PubMed ID: 21354326
[TBL] [Abstract][Full Text] [Related]
36. Toxicity testing and drug screening using iPSC-derived hepatocytes, cardiomyocytes, and neural cells.
Csöbönyeiová M; Polák Š; Danišovič L
Can J Physiol Pharmacol; 2016 Jul; 94(7):687-94. PubMed ID: 27128322
[TBL] [Abstract][Full Text] [Related]
37. In silico toxicology for the pharmaceutical sciences.
Valerio LG
Toxicol Appl Pharmacol; 2009 Dec; 241(3):356-70. PubMed ID: 19716836
[TBL] [Abstract][Full Text] [Related]
38. Human embryonic stem cell technologies and drug discovery.
Jensen J; Hyllner J; Björquist P
J Cell Physiol; 2009 Jun; 219(3):513-9. PubMed ID: 19277978
[TBL] [Abstract][Full Text] [Related]
39. Understanding mechanisms of toxicity: insights from drug discovery research.
Houck KA; Kavlock RJ
Toxicol Appl Pharmacol; 2008 Mar; 227(2):163-78. PubMed ID: 18063003
[TBL] [Abstract][Full Text] [Related]
40. Current and future needs for developmental toxicity testing.
Makris SL; Kim JH; Ellis A; Faber W; Harrouk W; Lewis JM; Paule MG; Seed J; Tassinari M; Tyl R
Birth Defects Res B Dev Reprod Toxicol; 2011 Oct; 92(5):384-94. PubMed ID: 21922641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
